The inter-relationship of periostin, TGFβ, and BMP in heart valve development and valvular heart diseases

TheScientificWorldJournal

Volumn 11, Issue , 2011, Pages 1509-1524

  Conway, Simon J ^a   Doetschman, Thomas ^b,c   Azhar, Mohamad ^b,c  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF ARIZONA   (United States)

^c UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

Author keywords

BMP; Bone morphogenetic protein; Heart development; Heart valves; Marfan syndrome; Periostin; TGF ; Transforming growth factor beta

Indexed keywords

BONE MORPHOGENETIC PROTEIN; BONE MORPHOGENETIC PROTEIN 2; COLLAGEN TYPE 1; COLLAGEN TYPE 5; FIBRILLIN 1; FIBRONECTIN; FILAMIN A; HEPARIN; MITOGEN ACTIVATED PROTEIN KINASE; RAS PROTEIN; SMAD PROTEIN; STABILIN 1; STABILIN 2; TENASCIN; TRANSCRIPTION FACTOR RUNX2; TRANSCRIPTION FACTOR YY1; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA2; UNCLASSIFIED DRUG;

ATRIOVENTRICULAR CANAL; CELL DIFFERENTIATION; CELL EXPANSION; CONCENTRATION (PARAMETERS); CONGENITAL HEART DISEASE; EPITHELIAL MESENCHYMAL TRANSITION; EXTRACELLULAR MATRIX; GENE EXPRESSION; GENE INACTIVATION; GENE MUTATION; HEART LEFT VENTRICLE OUTFLOW TRACT; HEART MUSCLE CELL; HEART VALVE; HOMEOSTASIS; MARFAN SYNDROME; MOLECULAR BIOLOGY; NONHUMAN; ORGANOGENESIS; PARACRINE SIGNALING; PATHOGENESIS; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REGULATORY MECHANISM; REVIEW; RHEUMATIC HEART DISEASE; TRANSCRIPTION INITIATION; VALVULAR HEART DISEASE;

BONE MORPHOGENETIC PROTEINS; CELL ADHESION MOLECULES; CELL DIFFERENTIATION; HEART VALVE DISEASES; HEART VALVES; HUMANS; MODELS, BIOLOGICAL; ORGANOGENESIS; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA;

EID: 84860390603     PISSN: None     EISSN: 1537744X     Source Type: Journal    
DOI: 10.1100/tsw.2011.132     Document Type: Review

References (130)

1. Pierpont, M.E., Basson, C.T., Benson, D.W., Jr., Gelb, B.D., Giglia, T.M., Goldmuntz, E., McGee, G., Sable, C.A., Srivastava, D., and Webb, C.L. (2007) Genetic basis for congenital heart defects: current knowledge: a scientific statement from the American Heart Association Congenital Cardiac Defects Committee, Council on Cardiovascular Disease in the Young: endorsed by the American Academy of Pediatrics. Circulation 115, 3015-3038.
2. Supino, P.G., Borer, J.S., Yin, A., Dillingham, E., and McClymont, W. (2004) The epidemiology of valvular heart diseases: the problem is growing. Adv. Cardiol. 41, 9-15.
3. Cripe, L., Andelfinger, G., Martin, L.J., Shooner, K., and Benson, D.W. (2004) Bicuspid aortic valve is heritable. J. Am. Coll. Cardiol. 44, 138-143.
4. Siu, S.C. and Silversides, C.K. (2010) Bicuspid aortic valve disease. J. Am. Coll. Cardiol. 55, 2789-2800.
5. Bartram, U., Bartelings, M.M., Kramer, H.H. and Gittenberger-de Groot, A.C. (2001) Congenital polyvalvular disease: a review. Pediatr. Cardiol. 22, 93-101.
6. Ward, C. (2000) Clinical significance of the bicuspid aortic valve. Heart 83, 81-85.
7. Wirrig, E.E., Hinton, R.B. and Yutzey, K.E. (2011) Differential expression of cartilage and bone-related proteins in pediatric and adult diseased aortic valves. J. Mol. Cell. Cardiol. 50, 561-569.
8. Caira, F.C., Stock, S.R., Gleason, T.G., McGee, E.C., Huang, J., Bonow, R.O., Spelsberg, T.C., McCarthy, P.M., Rahimtoola, S.H., and Rajamannan, N.M. (2006) Human degenerative valve disease is associated with up-regulation of low-density lipoprotein receptor-related protein 5 receptor-mediated bone formation. J. Am. Coll. Cardiol. 47, 1707-1712.
9. Barber, J.E., Kasper, F.K., Ratliff, N.B., Cosgrove, D.M., Griffin, B.P., and Vesely, I. (2001) Mechanical properties of myxomatous mitral valves. J. Thorac. Cardiovasc. Surg. 122, 955-962.
10. Wirrig, E.E. and Yutzey, K.E. (2011) Transcriptional regulation of heart valve development and disease. Cardiovasc. Pathol. 20, 162-167.
11. Lucas, R.V., Jr. and Edwards, J.E. (1982) The floppy mitral valve. Curr. Probl. Cardiol. 7, 1-48.
12. Tamura, K., Fukuda, Y., Ishizaki, M., Masuda, Y., Yamanaka, N., and Ferrans, V.J. (1995) Abnormalities in elastic fibers and other connective-tissue components of floppy mitral valve. Am. Heart J. 129, 1149-1158.
13. Grande-Allen, K.J., Griffin, B.P., Ratliff, N.B., Cosgrove, D.M., and Vesely, I. (2003) Glycosaminoglycan profiles of myxomatous mitral leaflets and chordae parallel the severity of mechanical alterations. J. Am. Coll. Cardiol. 42, 271-277.
14. Roth, B.L. (2007) Drugs and valvular heart disease. N. Engl. J. Med. 356, 6-9.
15. Gelb, B.D. (2006) Marfan's syndrome and related disorders - more tightly connected than we thought. N. Engl. J. Med. 355, 841-844.
16. Hennekam, R.C. (2005) Severe infantile Marfan syndrome versus neonatal Marfan syndrome. Am. J. Med. Genet. A 139, 1.
17. Ng, C.M., Cheng, A., Myers, L.A., Martinez-Murillo, F., Jie, C., Bedja, D., Gabrielson, K.L., Hausladen, J.M., Mecham, R.P., Judge, D.P., and Dietz, H.C. (2004) TGF-beta-dependent pathogenesis of mitral valve prolapse in a mouse model of Marfan syndrome. J. Clin. Invest. 114, 1586-1592.
18. Flores, M., Agosti, J., Damborenea, C., and Aguirre, C. (1984) Rheumatoid arthritis with severe aortic insufficiency and prolapse of the mitral valve. Scand. J. Rheumatol. 13, 28-32.
19. Kyndt, F., Gueffet, J.P., Probst, V., Jaafar, P., Legendre, A., Le Bouffant, F., Toquet, C., Roy, E., McGregor, L., Lynch, S.A., Newbury-Ecob, R., Tran, V., Young, I., Trochu, J.N., Le Marec, H., and Schott, J.J. (2007) Mutations in the gene encoding filamin A as a cause for familial cardiac valvular dystrophy. Circulation 115, 40-49.
20. Weismann, C.G. and Gelb, B.D. (2007) The genetics of congenital heart disease: a review of recent developments. Curr. Opin. Cardiol. 22, 200-206.
21. Snider, P., Hinton, R.B., Moreno-Rodriguez, R.A., Wang, J., Rogers, R., Lindsley, A., Li, F., Ingram, D.A., Menick, D., Field, L., Firulli, A.B., Molkentin, J.D., Markwald, R., and Conway, S.J. (2008) Periostin is required for maturation and extracellular matrix stabilization of noncardiomyocyte lineages of the heart. Circ. Res. 102, 752-760.
22. Markwald, R.R., Norris, R.A., Moreno-Rodriguez, R., and Levine, R.A. (2010) Developmental basis of adult cardiovascular diseases: valvular heart diseases. Ann. N. Y. Acad. Sci. 1188, 177-183.
23. Azhar, M., Schultz, J.E., Grupp, I., Dorn, G.W., Meneton, P., Molin, D.G., Gittenberger-de Groot, A.C., and Doetschman, T. (2003) Transforming growth factor beta in cardiovascular development and function. Cytokine Growth Factor Rev. 14, 391-407.
24. Arthur, H.M. and Bamforth, S.D. (2011) TGFbeta signaling and congenital heart disease: insights from mouse studies. Birth Defects Res. A Clin. Mol. Teratol. 91, 423-434.
25. Hakuno, D., Kimura, N., Yoshioka, M., and Fukuda, K. (2009) Molecular mechanisms underlying the onset of degenerative aortic valve disease. J. Mol. Med. 87, 17-24.
26. Gittenberger-de Groot, A.C., Bartelings, M.M., DeRuiter, M.C., and Poelmann, R.E. (2005) Basics of cardiac development for the understanding of congenital heart malformations. Pediatr. Res. 57, 169-176.
27. Lie-Venema, H., van den Akker, N.M., Bax, N.A., Winter, E.M., Maas, S., Kekarainen, T., Hoeben, R.C., DeRuiter, M.C., Poelmann, R.E., and Gittenberger-de Groot, A.C. (2007) Origin, fate, and function of epicardium-derived cells (EPDCs) in normal and abnormal cardiac development. TheScientificWorldJOURNAL 7, 1777-1798.
28. Hinton, R.B. and Yutzey, K.E. (2011) Heart valve structure and function in development and disease. Annu. Rev. Physiol. 73, 29-46.
29. Delaughter, D.M., Saint-Jean, L., Baldwin, H.S., and Barnett, J.V. (2011) What chick and mouse models have taught us about the role of the endocardium in congenital heart disease. Birth Defects Res. A Clin. Mol. Teratol. 91, 511-525.
30. Mercado-Pimentel, M.E. and Runyan, R.B. (2007) Multiple transforming growth factor-beta isoforms and receptors function during epithelial-mesenchymal cell transformation in the embryonic heart. Cells Tissues Organs 185, 146-156.
31. Butcher, J.T. and Markwald, R.R. (2007) Valvulogenesis: the moving target. Philos. Trans. R. Soc. Lond. B Biol. Sci. 362, 1489-1503.
32. Kruithof, B.P., Krawitz, S.A., and Gaussin, V. (2007) Atrioventricular valve development during late embryonic and postnatal stages involves condensation and extracellular matrix remodeling. Dev. Biol. 302, 208-217.
33. Huang, X.F. and Chai, Y. (2010) TGF-ss signalling and tooth development. Chin. J. Dent. Res. 13, 7-15.
34. Van Hemelrijk, C., Renard, M., and Loeys, B. (2010) The Loeys-Dietz syndrome: an update for the clinician. Curr. Opin. Cardiol. 25, 546-551.
35. Massague, J. (1998) TGF-beta signal transduction. Annu. Rev. Biochem. 67, 753-791.
36. Bragdon, B., Moseychuk, O., Saldanha, S., King, D., Julian, J., and Nohe, A. (2011) Bone morphogenetic proteins: a critical review. Cell Signal. 23, 609-620.
37. Litvin, J., Blagg, A., Mu, A., Matiwala, S., Montgomery, M., Berretta, R., Houser, S., and Margulies, K. (2006) Periostin and periostin-like factor in the human heart: possible therapeutic targets. Cardiovasc. Pathol. 15, 24-32.
38. Hamilton, D.W. (2008) Functional role of periostin in development and wound repair: implications for connective tissue disease. J. Cell Commun. Signal. 2, 9-17.
39. Norris, R.A., Moreno-Rodriguez, R.A., Sugi, Y., Hoffman, S., Amos, J., Hart, M.M., Potts, J.D., Goodwin, R.L., and Markwald, R.R. (2008) Periostin regulates atrioventricular valve maturation. Dev. Biol. 316, 200-213.
40. Levay, A.K., Peacock, J.D., Lu, Y., Koch, M., Hinton, R.B., Jr., Kadler, K.E., and Lincoln, J. (2008) Scleraxis is required for cell lineage differentiation and extracellular matrix remodeling during murine heart valve formation in vivo. Circ. Res. 103, 948-956.
41. Sanford, L.P., Ormsby, I., Gittenberger-de Groot, A.C., Sariola, H., Friedman, R., Boivin, G.P., Cardell, E.L., and Doetschman, T. (1997) TGFbeta2 knockout mice have multiple developmental defects that are non-overlapping with other TGFbeta knockout phenotypes. Development 124, 2659-2670.
42. Azhar, M., Runyan, R.B., Gard, C., Sanford, L.P., Miller, M.L., Andringa, A., Pawlowski, S., Rajan, S., and Doetschman, T. (2009) Ligand-specific function of transforming growth factor beta in epithelial-mesenchymal transition in heart development. Dev. Dyn. 238, 431-442.
43. Azhar, M., Brown, K., Gard, C., Chen, H.D.R., Rajan, S., Elliott, D.A., Stevens, M.V., Camenisch, T.D., Conway, S.J., and Doetschman, T. (2011) Transforming growth factor beta2 is required for valve remodeling during heart development. Dev. Dyn., in press.
44. van de Laar, I.M., Oldenburg, R.A., Pals, G., Roos-Hesselink, J.W., de Graaf, B.M., Verhagen, J.M., Hoedemaekers, Y.M., Willemsen, R., Severijnen, L.A., Venselaar, H., Vriend, G., Pattynama, P.M., Collee, M., Majoor-Krakauer, D., Poldermans, D., Frohn-Mulder, I.M., Micha, D., Timmermans, J., Hilhorst-Hofstee, Y., Bierma-Zeinstra, S.M., Willems, P.J., Kros, J.M., Oei, E.H., Oostra, B.A., Wessels, M.W., and Bertoli-Avella, A.M. (2011) Mutations in SMAD3 cause a syndromic form of aortic aneurysms and dissections with early-onset osteoarthritis. Nat. Genet. 43, 121-126.
45. Andrabi, S., Bekheirnia, M.R., Robbins-Furman, P., Lewis, R.A., Prior, T.W., and Potocki, L. (2011) SMAD4 mutation segregating in a family with juvenile polyposis, aortopathy, and mitral valve dysfunction. Am. J. Med. Genet. A 155A, 1165-1169.
46. Matt, P., Schoenhoff, F., Habashi, J., Holm, T., van Erp, C., Loch, D., Carlson, O.D., Griswold, B.F., Fu, Q., De Backer, J., Loeys, B., Huso, D.L., McDonnell, N.B., Van Eyk, J.E., Dietz, H.C.; GenTAC Consortium (2009) Circulating transforming growth factor-{beta} in Marfan syndrome. Circulation 120, 526-532
47. Loeys, B.L., Chen, J., Neptune, E.R., Judge, D.P., Podowski, M., Holm, T., Meyers, J., Leitch, C.C., Katsanis, N., Sharifi, N., Xu, F.L., Myers, L.A., Spevak, P.J., Cameron, D.E., De Backer, J., Hellemans, J., Chen, Y., Davis, E.C., Webb, C.L., Kress, W., Coucke, P., Rifkin, D.B., De Paepe, A.M., and Dietz, H.C. (2005) A syndrome of altered cardiovascular, craniofacial, neurocognitive and skeletal development caused by mutations in TGFBR1 or TGFBR2. Nat. Genet. 37, 275-281.
48. Kim, L., Kim, D.K., Yang, W.I., Shin, D.H., Jung, I.M., Park, H.K., and Chang, B.C. (2008) Overexpression of transforming growth factor-beta 1 in the valvular fibrosis of chronic rheumatic heart disease. J. Korean Med. Sci. 23, 41-48.
49. Kaden, J.J., Bickelhaupt, S., Grobholz, R., Vahl, C.F., Hagl, S., Brueckmann, M., Haase, K.K., Dempfle, C.E., and Borggrefe, M. (2004) Expression of bone sialoprotein and bone morphogenetic protein-2 in calcific aortic stenosis. J. Heart Valve Dis. 13, 560-566.
50. Snider, P., Standley, K.N., Wang, J., Azhar, M., Doetschman, T., and Conway, S.J. (2009) Origin of cardiac fibroblasts and the role of periostin. Circ. Res. 105, 934-947.
51. Conway, S.J. and Molkentin, J.D. (2008) Periostin as a heterofunctional regulator of cardiac development and disease. Curr. Genomics 9, 548-555.
52. Gillan, L., Matei, D., Fishman, D.A., Gerbin, C.S., Karlan, B.Y., and Chang, D.D. (2002) Periostin secreted by epithelial ovarian carcinoma is a ligand for alpha(V)beta(3) and alpha(V)beta(5) integrins and promotes cell motility. Cancer Res. 62, 5358-5364.
53. Baril, P., Gangeswaran, R., Mahon, P.C., Caulee, K., Kocher, H.M., Harada, T., Zhu, M., Kalthoff, H., Crnogorac-Jurcevic, T., and Lemoine, N.R. (2007) Periostin promotes invasiveness and resistance of pancreatic cancer cells to hypoxia-induced cell death: role of the beta4 integrin and the PI3k pathway. Oncogene 26, 2082-2094.
54. Ruan, K., Bao, S., and Ouyang, G. (2009) The multifaceted role of periostin in tumorigenesis. Cell. Mol. Life Sci. 66, 2219-2230.
55. Kruzynska-Frejtag, A., Machnicki, M., Rogers, R., Markwald, R.R., and Conway, S.J. (2001) Periostin (an osteoblast-specific factor) is expressed within the embryonic mouse heart during valve formation. Mech. Dev. 103, 183-188.
56. Erkan, M., Kleeff, J., Gorbachevski, A., Reiser, C., Mitkus, T., Esposito, I., Giese, T., Buchler, M.W., Giese, N.A., and Friess, H. (2007) Periostin creates a tumor-supportive microenvironment in the pancreas by sustaining fibrogenic stellate cell activity. Gastroenterology 132, 1447-1464.
57. Kim, C.J., Yoshioka, N., Tambe, Y., Kushima, R., Okada, Y., and Inoue, H. (2005) Periostin is down-regulated in high grade human bladder cancers and suppresses in vitro cell invasiveness and in vivo metastasis of cancer cells. Int. J. Cancer 117, 51-58.
58. Meulmeester, E. and ten Dijke, P. (2011) The dynamic roles of TGF-beta in cancer. J. Pathol. 223, 205-218.
59. Massague, J. (2008) TGFbeta in Cancer. Cell 134, 215-230.
60. Blanco Calvo, M., Bolós Fernández, V., Medina Villaamil, V., Aparicio Gallego, G., Díaz Prado, S., and Grande Pulido, E. (2009) Biology of BMP signalling and cancer. Clin. Transl. Oncol. 11, 126-137.
61. Takeshita, S., Kikuno, R., Tezuka, K., and Amann, E. (1993) Osteoblast-specific factor 2: cloning of a putative bone adhesion protein with homology with the insect protein fasciclin I. Biochem. J. 294, 271-278.
62. Rios, H., Koushik, S.V., Wang, H., Wang, J., Zhou, H.M., Lindsley, A., Rogers, R., Chen, Z., Maeda, M., Kruzynska-Frejtag, A., Feng, J.Q., and Conway, S.J. (2005) Periostin null mice exhibit dwarfism, incisor enamel defects, and an early-onset periodontal disease-like phenotype. Mol. Cell. Biol. 25, 11131-11144.
63. Kashima, T.G., Nishiyama, T., Shimazu, K., Shimazaki, M., Kii, I., Grigoriadis, A.E., Fukayama, M., and Kudo, A. (2009) Periostin, a novel mar ker of intramembranous ossification, is expressed in fibrous dysplasia and in c-Fos-overexpressing bone lesions. Hum. Pathol. 40, 226-237.
64. Serra, R. and Chang, C. (2003) TGF-beta signaling in human skeletal and patterning disorders. Birth Defects Res. C Embryo Today 69, 333-351.
65. Lincoln, J., Lange, A.W., and Yutzey, K.E. (2006) Hearts and bones: shared regulatory mechanisms in heart valve, cartilage, tendon, and bone development. Dev. Biol. 294, 292-302.
66. Chakraborty, S., Cheek, J., Sakthivel, B., Aronow, B.J., and Yutzey, K.E. (2008) Shared gene expression profiles in developing heart valves and osteoblast progenitor cells. Physiol. Genomics. 35, 75-85.
67. Tkatchenko, T.V., Moreno-Rodriguez, R.A., Conway, S.J., Molkentin, J.D., Markwald, R.R., and Tkatchenko, A.V. (2009) Lack of periostin leads to suppression of Notch1 signaling and calcific aortic valve disease. Physiol. Genomics 39, 160-168.
68. Annes, J.P., Munger, J.S., and Rifkin, D.B. (2003) Making sense of latent TGFbeta activation. J. Cell Sci. 116, 217-224.
69. Ramirez, F. and Rifkin, D.B. (2009) Extracellular microfibrils: contextual platforms for TGFbeta and BMP signaling. Curr. Opin. Cell Biol. 21, 616-622.
70. Kang, J.S., Liu, C., and Derynck, R. (2009) New regulatory mechanisms of TGF-beta receptor function. Trends Cell Biol. 19, 385-394.
71. Brown, C.B., Boyer, A.S., Runyan, R.B., and Barnett, J.V. (1999) Requirement of type III TGF-beta receptor for endocardial cell transformation in the heart. Science 283, 2080-2082.
72. ten Dijke, P., Goumans, M.J., and Pardali, E. (2008) Endoglin in angiogenesis and vascular diseases. Angiogenesis 11, 79-89.
73. Goumans, M.J., Liu, Z., and ten Dijke, P. (2008) TGF-beta signaling in vascular biology and dysfunction. Cell Res. 19, 116-127.
74. Pece-Barbara, N., Vera, S., Kathirkamathamby, K., Liebner, S., Di Guglielmo, G.M., Dejana, E., Wrana, J.L., and Letarte, M. (2005) Endoglin null endothelial cells proliferate faster and are more responsive to transforming growth factor beta1 with higher affinity receptors and an activated Alk1 pathway. J. Biol. Chem. 280, 27800-27808.
75. Kim, Y., Kugler, M.C., Wei, Y., Kim, K.K., Li, X., Brumwell, A.N., and Chapman, H.A. (2009) Integrin alpha3beta1-dependent beta-catenin phosphorylation links epithelial Smad signaling to cell contacts. J. Cell Biol. 184, 309-322.
76. Li, P., Pashmforoush, M., and Sucov, H.M. (2010) Retinoic acid regulates differentiation of the secondary heart field and TGFbeta-mediated outflow tract septation. Dev. Cell 18, 480-485.
77. Hoover, L.L., Burton, E.G., Brooks, B.A., and Kubalak, S.W. (2008) The expanding role for retinoid signaling in heart development. TheScientificWorldJOURNAL 8, 194-211.
78. Miyazono, K., Kamiya, Y., and Morikawa, M. (2010) Bone morphogenetic protein receptors and signal transduction. J. Biochem. 147, 35-51.
79. Goto, K., Kamiya, Y., Imamura, T., Miyazono, K., and Miyazawa, K. (2007) Selective inhibitory effects of Smad6 on bone morphogenetic protein type I receptors. J. Biol. Chem. 282, 20603-20611.
80. Tang, S., Snider, P., Firulli, A.B., and Conway, S.J. (2010) Trigenic neural crest-restricted Smad7 over-expression results in congenital craniofacial and cardiovascular defects. Dev. Biol. 344, 233-247.
81. Kirkbride, K.C., Townsend, T.A., Bruinsma, M.W., Barnett, J.V., and Blobe, G.C. (2008) Bone morphogenetic proteins signal through the transforming growth factor-beta type III receptor. J. Biol. Chem. 283, 7628-7637.
82. Townsend, T.A., Robinson, J.Y., Deig, C.R., Hill, C.R., Misfeldt, A., Blobe, G.C., and Barnett, J.V. (2011) BMP-2 and TGFbeta2 shared pathways regulate endocardial cell transformation. Cells Tissues Organs 194, 1-12.
83. Daly, A.C., Randall, R.A., and Hill, C.S. (2008) Transforming growth factor beta-induced Smad1/5 phosphorylation in epithelial cells is mediated by novel receptor complexes and is essential for anchorage-independent growth. Mol. Cell. Biol. 28, 6889-6902.
84. Molin, D.G., Bartram, U., Van der Heiden, K., Van Iperen, L., Speer, C.P., Hierck, B.P., Poelmann, R.E., and Gittenberger-de-Groot, A.C. (2003) Expression patterns of Tgfbeta1-3 associate with myocardialisation of the outflow tract and the development of the epicardium and the fibrous heart skeleton. Dev. Dyn. 227, 431-444.
85. Camenisch, T.D., Molin, D.G., Person, A., Runyan, R.B., Gittenberger-de Groot, A.C., McDonald, J.A., and Klewer, S.E. (2002) Temporal and distinct TGFbeta ligand requirements during mouse and avian endocardial cushion morphogenesis. Dev. Biol. 248, 170-181.
86. Akhurst, R.J., Lehnert, S.A., Faissner, A., and Duffie, E. (1990) TGF beta in murine morphogenetic processes: the early embryo and cardiogenesis. Development 108, 645-656.
87. Dickson, M.C., Slager, H.G., Duffie, E., Mummery, C.L., and Akhurst, R.J. (1993) RNA and protein localisations of TGF beta 2 in the early mouse embryo suggest an involvement in cardiac development. Development 117, 625-639.
88. Millan, F.A., Denhez, F., Kondaiah, P., and Akhurst, R.J. (1991) Embryonic gene expression patterns of TGF beta 1, beta 2 and beta 3 suggest different developmental functions in vivo. Development 111, 131-143.
89. Vrljicak, P., Chang, A.C., Morozova, O., Wederell, E.D., Niessen, K., Marra, M.A., Karsan, A., and Hoodless, P.A. (2010) Genomic analysis distinguishes phases of early development of the mouse atrio-ventricular canal. Physiol. Genomics 40, 150-157.
90. Beffagna, G., Occhi, G., Nava, A., Vitiello, L., Ditadi, A., Basso, C., Bauce, B., Carraro, G., Thiene, G., Towbin, J.A., Danieli, G.A., and Rampazzo, A. (2005) Regulatory mutations in transforming growth factor-beta3 gene cause arrhythmogenic right ventricular cardiomyopathy type 1. Cardiovasc. Res. 65, 366-373.
91. Hu, B.C., Li, L., Sun, R.H., Gao, P.J., Zhu, D.L., Wang, J.G., and Chu, S.L. (2010) The association between transforming growth factor beta3 polymorphisms and left ventricular structure in hypertensive subjects. Clin. Chim. Acta 411, 558-562.
92. Teekakirikul, P., Eminaga, S., Toka, O., Alcalai, R., Wang, L., Wakimoto, H., Nayor, M., Konno, T., Gorham, J.M., Wolf, C.M., Kim, J.B., Schmitt, J.P., Molkentin, J.D., Norris, R.A., Tager, A.M., Hoffman, S.R., Markwald, R.R., Seidman, C.E., and Seidman, J.G. (2010) Cardiac fibrosis in mice with hypertrophic cardiomyopathy is mediated by non-myocyte proliferation and requires Tgf-beta. J. Clin. Invest. 120, 3520-3529.
93. Yang, J.H., Wylie-Sears, J., and Bischoff, J. (2008) Opposing actions of Notch1 and VEGF in post-natal cardiac valve endothelial cells. Biochem. Biophys. Res. Commun. 374, 512-516.
94. Shull, M.M., Ormsby, I., Kier, A.B., Pawlowski, S., Diebold, R.J., Yin, M., Allen, R., Sidman, C., Proetzel, G., Calvin, D., and Doetschman, T. (1992) Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease. Nature 359, 693-699.
95. Proetzel, G., Pawlowski, S.A., Wiles, M.V., Yin, M., Boivin, G.P., Howles, P.N., Ding, J., Ferguson, M.W., and Doetschman, T. (1995) Transforming growth factor-beta 3 is required for secondary palate fusion. Nat. Genet. 11, 409-414.
96. Bartram, U., Molin, D.G., Wisse, L.J., Mohamad, A., Sanford, L.P., Doetschman, T., Speer, C.P., Poelmann, R.E., and Gittenberger-de Groot, A.C. (2001) Double-outlet right ventricle and overriding tricuspid valve reflect disturbances of looping, myocardialization, endocardial cushion differentiation, and apoptosis in Tgfb2 knockout mice. Circulation 103, 2745-2752.
97. Wang, J., Greene, S.B., and Martin, J.F. (2011) BMP signaling in congenital heart disease: new developments and future directions. Birth Defects Res. A Clin. Mol. Teratol. 91, 441-448.
98. Ma, L., Lu, M.F., Schwartz, R.J., and Martin, J.F. (2005) Bmp2 is essential for cardiac cushion epithelial-mesenchymal transition and myocardial patterning. Development 132, 5601-5611.
99. Delot, E.C. (2003) Control of endocardial cushion and cardiac valve maturation by BMP signaling pathways. Mol. Genet. Metab. 80, 27-35.
100. Liu, W., Selever, J., Wang, D., Lu, M.F., Moses, K.A., Schwartz, R.J., and Martin, J.F. (2004) Bmp4 signaling is required for outflow-tract septation and branchial-arch artery remodeling. Proc. Natl. Acad. Sci. U. S. A. 101, 4489-4494.
101. Kim, R.Y., Robertson, E.J., and Solloway, M.J. (2001) Bmp6 and Bmp7 are required for cushion formation and septation in the developing mouse heart. Dev. Biol. 235, 449-466.
102. Sugi, Y., Yamamura, H., Okagawa, H., and Markwald, R.R. (2004) Bone morphogenetic protein-2 can mediate myocardial regulation of atrioventricular cushion mesenchymal cell formation in mice. Dev. Biol. 269, 505-518.
103. Kajbaf, S., Veinot, J.P., Ha, A., and Zimmerman, D. (2005) Comparison of surgically removed cardiac valves of patients with ESRD with those of the general population. Am. J. Kidney Dis. 46, 86-93.
104. Uchimura, T., Komatsu, Y., Tanaka, M., McCann, K.L., and Mishina, Y. (2009) Bmp2 and Bmp4 genetically interact to support multiple aspects of mouse development including functional heart development. Genesis 47, 374-384.
105. Delot, E.C., Bahamonde, M.E., Zhao, M., and Lyons, K.M. (2003) BMP signaling is required for septation of the outflow tract of the mammalian heart. Development 130, 209-220.
106. Jiao, K., Kulessa, H., Tompkins, K., Zhou, Y., Batts, L., Baldwin, H.S., and Hogan, B.L. (2003) An essential role of Bmp4 in the atrioventricular septation of the mouse heart. Genes Dev. 17, 2362-2367.
107. Beppu, H., Malhotra, R., Beppu, Y., Lepore, J.J., Parmacek, M.S., and Bloch, K.D. (2009) BMP type II receptor regulates positioning of outflow tract and remodeling of atrioventricular cushion during cardiogenesis. Dev. Biol. 331, 167-175.
108. McCulley, D.J., Kang, J.O., Martin, J.F., and Black, B.L. (2008) BMP4 is required in the anterior heart field and its derivatives for endocardial cushion remodeling, outflow tract septation, and semilunar valve development. Dev. Dyn. 237, 3200-3209.
109. Choi, M., Stottmann, R.W., Yang, Y.P., Meyers, E.N., and Klingensmith, J. (2007) The bone morphogenetic protein antagonist noggin regulates mammalian cardiac morphogenesis. Circ. Res. 100, 220-228.
110. Galvin, K.M., Donovan, M.J., Lynch, C.A., Meyer, R.I., Paul, R.J., Lorenz, J.N., Fairchild-Huntress, V., Dixon, K.L., Dunmore, J.H., Gimbrone, M.A., Jr., Falb, D., and Huszar, D. (2000) A role for smad6 in development and homeostasis of the cardiovascular system. Nat. Genet. 24, 171-174.
111. Rivera-Feliciano, J. and Tabin, C.J. (2006) Bmp2 instructs cardiac progenitors to form the heart-valve-inducing field. Dev. Biol. 295, 580-588.
112. Bharathy, S., Xie, W., Yingling, J.M., and Reiss, M. (2008) Cancer-associated transforming growth factor beta type II receptor gene mutant causes activation of bone morphogenic protein-Smads and invasive phenotype. Cancer Res. 68, 1656-1666.
113. Wang, J., Sridurongrit, S., Dudas, M., Thomas, P., Nagy, A., Schneider, M.D., Epstein, J.A., and Kaartinen, V. (2005) Atrioventricular cushion transformation is mediated by ALK2 in the developing mouse heart. Dev. Biol. 286, 299-310.
114. Gaussin, V., Morley, G.E., Cox, L., Zwijsen, A., Vance, K.M., Emile, L., Tian, Y., Liu, J., Hong, C., Myers, D., Conway, S.J., Depre, C., Mishina, Y., Behringer, R.R., Hanks, M.C., Schneider, M.D., Huylebroeck, D., Fishman, G.I., Burch, J.B., and Vatner, S.F. (2005) Alk3/Bmpr1a receptor is required for development of the atrioventricular canal into valves and annulus fibrosus. Circ. Res. 97, 219-226.
115. Barnett, J.V. and Desgrosellier, J.S. (2003) Early events in valvulogenesis: a signaling perspective. Birth Defects Res. C Embryo Today 69, 58-72.
116. Lindsley, A., Snider, P., Zhou, H., Rogers, R., Wang, J., Olaopa, M., Kruzynska-Frejtag, A., Koushik, S.V., Lilly, B., Burch, J.B., Firulli, A.B., and Conway, S.J. (2007) Identification and characterization of a novel Schwann and outflow tract endocardial cushion lineage-restricted periostin enhancer. Dev. Biol. 307, 340-355.
117. Lee, K.H., Evans, S., Ruan, T.Y., and Lassar, A.B. (2004) SMAD-mediated modulation of YY1 activity regulates the BMP response and cardiac-specific expression of a GATA4/5/6-dependent chick Nkx2.5 enhancer. Development 131, 4709-4723.
118. Kurisaki, K., Kurisaki, A., Valcourt, U., Terentiev, A.A., Pardali, K., ten Dijke, P., Heldin, C.H., Ericsson, J., and Moustakas, A. (2003) Nuclear factor YY1 inhibits transforming growth factor beta- and bone morphogenetic protein-induced cell differentiation. Mol. Cell. Biol. 23, 4494-4510.
119. Horiuchi, K., Amizuka, N., Takeshita, S., Takamatsu, H., Katsuura, M., Ozawa, H., Toyama, Y., Bonewald, L.F., and Kudo, A. (1999) Identification and characterization of a novel protein, periostin, with restricted expression to periosteum and periodontal ligament and increased expression by transforming growth factor beta. J. Bone Miner. Res. 14, 1239-1249.
120. Zhou, H.M., Wang, J., Elliott, C., Wen, W., Hamilton, D.W., and Conway, S.J. (2010) Spatiotemporal expression of periostin during skin development and incisional wound healing: lessons for human fibrotic scar formation. J. Cell Commun. Signal. 4, 99-107.
121. Norris, R.A., Potts, J.D., Yost, M.J., Junor, L., Brooks, T., Tan, H., Hoffman, S., Hart, M.M., Kern, M.J., Damon, B., Markwald, R.R., and Goodwin, R.L. (2009) Periostin promotes a fibroblastic lineage pathway in atrioventricular valve progenitor cells. Dev. Dyn. 238, 1052-1063.
122. Li, G., Oparil, S., Sanders, J.M., Zhang, L., Dai, M., Chen, L.B., Conway, S.J., McNamara, C.A., and Sarembock, I.J. (2006) Phosphatidylinositol-3- kinase signaling mediates vascular smooth muscle cell expression of periostin in vivo and in vitro. Atherosclerosis 188, 292-300.
123. Snider, P., Olaopa, M., Firulli, A.B., and Conway, S.J. (2007) Cardiovascular development and the colonizing cardiac neural crest lineage. TheScientificWorldJOURNAL 7, 1090-1113.
124. Jiang, X., Rowitch, D.H., Soriano, P., McMahon, A.P., and Sucov, H.M. (2000) Fate of the mammalian cardiac neural crest. Development 127, 1607-1616.
125. Molin, D.G., Poelmann, R.E., DeRuiter, M.C., Azhar, M., Doetschman, T., and Gittenberger-de Groot, A.C. (2004) Transforming growth factor beta-SMAD2 signaling regulates aortic arch innervation and development. Circ. Res. 95, 1109-1117.
126. Cohn, R.D., van Erp, C., Habashi, J.P., Soleimani, A.A., Klein, E.C., Lisi, M.T., Gamradt, M., ap Rhys, C.M., Holm, T.M., Loeys, B.L., Ramirez, F., Judge, D.P., Ward, C.W., and Dietz, H.C. (2007) Angiotensin II type 1 receptor blockade attenuates TGF-beta-induced failure of muscle regeneration in multiple myopathic states. Nat. Med. 13, 204-210.
127. Walker, G.A., Masters, K.S., Shah, D.N., Anseth, K.S., and Leinwand, L.A. (2004) Valvular myofibroblast activation by transforming growth factor-beta: implications for pathological extracellular matrix remodeling in heart valve disease. Circ. Res. 95, 253-260.
128. Lie-Venema, H., Eralp, I., Markwald, R.R., van den Akker, N.M., Wijffels, M.C., Kolditz, D.P., van der Laarse, A., Schalij, M.J., Poelmann, R.E., Bogers, A.J., and Gittenberger-de Groot, A.C. (2008) Periostin expression by epicardium-derived cells is involved in the development of the atrioventricular valves and fibrous heart skeleton. Differentiation 76, 809-819.
129. Ji, X., Chen, D., Xu, C., Harris, S.E., Mundy, G.R., and Yoneda, T. (2000) Patterns of gene expression associated with BMP-2-induced osteoblast and adipocyte differentiation of mesenchymal progenitor cell 3T3-F442A. J. Bone Miner. Metab. 18, 132-139.
130. Inai, K., Norris, R.A., Hoffman, S., Markwald, R.R., and Sugi, Y. (2008) BMP-2 induces cell migration and periostin expression during atrioventricular valvulogenesis. Dev. Biol. 315, 383-396.